Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Ancient eggshells shed new light on crocodiles that hunted prey from trees - 2Thousands of New York City nurses set to strike Monday if deal isn't reached with hospitals
- 3What to watch for in weight loss drugs in 2026
- 4Man threatens attack on German high-speed train, injures several
- 5Best Food Truck Cooking: Decision in favor of Your Number one!
- The Latest: Fueling begins as NASA aims to send 1st crew to the moon in 53 years
- Instructions to Pick the Ideal SUV Size for Seniors
- Productive CRM Programming for Client Relationship The executives
- Find the Wonders of the Silk Street: Following the Antiquated Shipping lanes
- Unusual 'ingredients' helped stars form in a galaxy near the Milky Way
- Excelling at Discussion: Genuine Examples of overcoming adversity
- How to watch 'A Charlie Brown Christmas' for free in 2025
- 5 Different ways Macintosh is Prepared to Overwhelm Gaming, Even Against Windows
- Instructions to Grasp the Innovation Behind 5G Pinnacles\
